Product Images Finasteride

This appears to be a figure from a medical study evaluating the percent of patients having surgery for BPH (benign prostatic hyperplasia) and the effect of Finasteride compared to a Placebo. The percent of patients having surgery for BPH, including TURP (Transurethral resection of the prostate), is shown in a graph over an observation time of 48 months. The placebo group had 37 events cumulatively, and the finasteride group had 18 events cumulatively. The number at risk per year is also shown for each group.*

The text describes a figure showing the percentage of patients who developed acute urinary retention (spontaneous and precipitated) over a period of observation time (in months). The percentage ranges from 0 to 20% and is higher in the placebo group. There is also information on the cumulative number of events and the number at risk for each group at different observation times. Not available.*

This is a description of a medication called Finasteride, printed on a bottle that contains 500 tablets of 5mg each. The recommended dosage for adults is one tablet per day., and the tablets should be stored at a temperature of 20°C to 25°C in a closed container, away from light. The medication should not be taken by women and children, or handled by women who are pregnant or may potentially become pregnant. The manufacturer is Auwobiodo Banm Finiiad & M, based in Hyderabad, India, and the medication is distributed by Quallent Pharmaceuticals Health LLC, in Grand Cayman, Cayman Islands. The packaging includes a circular that provides additional information on the medication. The text also includes information regarding printing details that will be printed during packing.*